These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 8510707

  • 1. Prognosis of untreated patients with idiopathic membranous nephropathy.
    Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G.
    N Engl J Med; 1993 Jul 08; 329(2):85-9. PubMed ID: 8510707
    [Abstract] [Full Text] [Related]

  • 2. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
    Nephrol Dial Transplant; 2008 Aug 08; 23(8):2546-51. PubMed ID: 18308774
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug 08; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 4. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May 08; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
    Passerini P, Pasquali S, Cesana B, Zucchelli P, Ponticelli C.
    Nephrol Dial Transplant; 1989 May 08; 4(6):525-9. PubMed ID: 2507973
    [Abstract] [Full Text] [Related]

  • 6. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul 08; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May 08; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 8. Membranous nephropathy: a 19 year prospective study in 51 patients.
    Hay NM, Bailey RR, Lynn KL, Robson RA.
    N Z Med J; 1992 Dec 09; 105(947):489-91. PubMed ID: 1461605
    [Abstract] [Full Text] [Related]

  • 9. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
    Polanco N, Gutiérrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D, Praga M, Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN).
    Nephrol Dial Transplant; 2012 Jan 09; 27(1):231-4. PubMed ID: 21624942
    [Abstract] [Full Text] [Related]

  • 10. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF, Branten AJ, Deegens JK, Steenbergen E, Wetzels JF.
    Nephrol Dial Transplant; 2007 Aug 09; 22(8):2201-7. PubMed ID: 17442739
    [Abstract] [Full Text] [Related]

  • 11. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.
    Laluck BJ, Cattran DC.
    Am J Kidney Dis; 1999 Jun 09; 33(6):1026-32. PubMed ID: 10352189
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
    N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
    [Abstract] [Full Text] [Related]

  • 13. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan 05; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 14. [Membranous glomerulonephritis].
    Polenaković M.
    Srp Arh Celok Lek; 1996 Jan 05; 124 Suppl 1():18-25. PubMed ID: 9102898
    [Abstract] [Full Text] [Related]

  • 15. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF.
    Am J Kidney Dis; 2005 Dec 05; 46(6):1012-29. PubMed ID: 16310567
    [Abstract] [Full Text] [Related]

  • 16. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases.
    Murphy BF, Fairley KF, Kincaid-Smith PS.
    Clin Nephrol; 1988 Oct 05; 30(4):175-81. PubMed ID: 3214963
    [Abstract] [Full Text] [Related]

  • 17. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N, Robeva R, Dimitrova V.
    Vutr Boles; 1990 Oct 05; 29(3):53-60. PubMed ID: 2284800
    [Abstract] [Full Text] [Related]

  • 18. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2010 Jan 05; 25(1):129-36. PubMed ID: 19666912
    [Abstract] [Full Text] [Related]

  • 19. Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine.
    Mok CC, Ying KY, Yim CW, Ng WL, Wong WS.
    Lupus; 2009 Oct 05; 18(12):1091-5. PubMed ID: 19762384
    [Abstract] [Full Text] [Related]

  • 20. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
    Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S.
    N Engl J Med; 1989 Jan 26; 320(4):210-5. PubMed ID: 2643046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.